are glp 1 drugs safe for older adults While GLP-1 receptor agonists widely used diabetes and weight management, clinicians should exercise extra caution in adults, who often have complex health profiles. These patients may face higher risk GLP-1 use peaks in middle
Description
Regional Insights: North America holds 42%, Europe 28%, Asia-Pacific 22%, Middle East & Africa 8%, driven by adoption rates and healthcare expansion
This makes it an ideal weapon against type 2 diabetes
& Lacroix, A
Victoza (liraglutide) : a once-daily injectable GLP-1 receptor agonist, also sold in a higher dose for weight loss under the brand name Saxenda
The detailed demographic and clinical characteristics of the participants are provided in Supplementary Tables S3 and S4
